[ Price : $8.95]
FDA extends by three months its review of an Omeros resubmitted BLA for narsoplimab in hematopoietic stem cell transplant-associat...[ Price : $8.95]
FDA approves a Precigen BLA for Papzimeos (zopapogene imadenovec-drba), a non-replicating adenoviral vector-based immunotherapy fo...[ Price : $8.95]
FDA issues an alert after becoming aware that Medtronic recently sent a letter to customers recommending that certain DLP Left Hea...[ Price : $8.95]
A Phase 3 study of Pfizers investigational sickle cell disease drug inclacumab fails to meet the primary endpoint.[ Price : $8.95]
FDA grants Beam Therapeutics a Regenerative Medicine Advanced Therapy designation for BEAM-101, an investigational gene-edited cel...[ Price : $8.95]
The Multidisciplinary Association for Psychedelic Studies calls on HHS and FDA to quickly approve its NDA for MDMA-assisted therap...[ Price : $8.95]
President Trump issues an Executive Order requiring HHS to obtain critical drug active pharmaceutical ingredients to be stored in ...[ Price : $8.95]
After two deaths in trial, Schrdinger decides to stop developing SGR-2921, its CDC7 inhibitor being evaluated in a Phase 1 dose-es...